FindTrial
Sign In

The effect of partial splenic artery embolization on portal vein thrombosis

The effect of partial splenic artery embolization on portal vein thrombosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048291
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal vein thrombosis

Interventions

partial splenic artery embolization Group versus partial splenic artery embolization not performed :No

Sponsors

Nanchang University Affiliated Ganzhou Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of liver cirrhosis were included as the control group, and patients with liver cirrhosis who underwent partial splenic artery embolization were included in the experimental group.

Exclusion criteria

Exclusion criteria: 1. Patients with serious complications such as hepatic encephalopathy; 2. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
The incidence of portal vein thrombosis;Blood routine;Liver function;Four items of blood coagulation;—

Countries

China

Contacts

Public ContactHuang Jiaming

Nanchang University Affiliated Ganzhou Hospital

victor471842@126.com+86 13576738711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026